Skip to main content
SpringerLink
Log in

Therapie der chronischen Herzinsuffizienz mit ACE-Hemmern versus AT1-Rezeptor-Antagonisten

Gibt es Unterschiede?

  • Bundesverband Niedergelassener Kardiologen
  • Die Persönliche Meinung
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Christen Y, Waeber B, Nussberger J, Brunner HR. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogeneous angiotensin I and II. Circulation 1991;83:1333–42.

    PubMed  CAS  Google Scholar 

  2. Correspondence to the ELITE study. Losartan versus captopril in elderly patients with heart failure. Lancet 1997;349:1473–5.

    Google Scholar 

  3. Crozier I, Ikram H, Awan N. Losartan in heart failure: hemodynamic effects and tolerability. Circulation 1995;91:691–7.

    PubMed  CAS  Google Scholar 

  4. Dickstein K, Chang P, Willenheimer R, et al. Comparison of the effects of Losartan and Enalapril on clinical status and exercise performanec in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 1995;26:438–45.

    Article  PubMed  CAS  Google Scholar 

  5. Gansevoort RT, de Zeuw D., de Jong P.E. Is the antiproteinuric effect of ACE-Inhibition mediated by interference in the renin angiotensin system? Kiney Int 1994;45:861–7.

    Article  CAS  Google Scholar 

  6. Goldberg MA, Tanaka W, Barchowsky A, et al. Effects of Losartan on blood pressure, plasma renin activity and angiotensin II in healthy volunteers. Hypertension 1993;21:704–13.

    PubMed  CAS  Google Scholar 

  7. Gottlieb SS, Dickstein K, Fleck E, et al. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 1993;88:1602–9.

    PubMed  CAS  Google Scholar 

  8. Johnston CI. Angiotensin converting enzyme inhibition. In: Robertson JIS, Nichols MG, eds. The renin angiotensin system. Gower Medical Publ., 1993: 87.1–87.15.

  9. Johnston CI. Angiotensin receptor antagonist: focus on losartan. Lancet 1995; 346:1403–7.

    Article  PubMed  CAS  Google Scholar 

  10. Lo MW, Goldberg MR, McCrea JB, Lu H, Furek CL, Bjornson D. Pharmakokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther 1995;58:641–9.

    Article  PubMed  CAS  Google Scholar 

  11. Milavetz JJ, Raya TE, Johnson C, Morkin E, Goldmann S. Survival after myocardial infarction in rats: Captopril versus Losartan. J Am Coll Cardiol 1996;27:714–9.

    Article  PubMed  CAS  Google Scholar 

  12. Pitt B. Evaluation of Losartan in the elderly trial (ELITE): Clinical implications. Eur Heart J 1997;18:1197–9.

    PubMed  CAS  Google Scholar 

  13. Pitt B, Segal R, Martinez G, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet 1997;349:747–52.

    Article  PubMed  CAS  Google Scholar 

  14. Regitz-Zagrosek V, Neuss M, Fleck E. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects. Eur Heart J 1995; 16:86–91.

    PubMed  CAS  Google Scholar 

  15. Ruzicka M, Yuan B, Leenen FHH. Effects of Enalapril versus Losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 1994; 90:484–91.

    PubMed  CAS  Google Scholar 

  16. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic ACE-inhibition and ATl-blockade on cardiac remodeling after myocardial infarction. Circulation 1994;89:2273–82.

    PubMed  CAS  Google Scholar 

  17. Schieffer B, Wollert KC, Berchtold M, et al. Development and prevention of skeletal muscle structural alterations in experimental chronic heart failure. Am J Physiol 1995;269:H1507-H1513.

    PubMed  CAS  Google Scholar 

  18. Smits JFM, van Krimpen C, Schoemakers RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: Effect on hemodynamics, myocardial DNA synthesis and interstitial collagen content. J Cardiovasc Res 1992;20:272–278.

    Google Scholar 

  19. Timmermanns PBMWM, Wong PC, Chiu AT, Duncia JV. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205–30.

    Google Scholar 

  20. Urata H, Boehm K, Philip A. Human chymase: Cellular localization and regional distribution of a major angiotensin II-forming enzyme in the heart. J Clin Invest 1993;91:1269–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Kardiologie, Zentrum Innere Medizin, Medizinische Hochschule, Carl-Neuberg-Straße 1, D-30625, Hannover

    B. Schieffer & H. Drexler

Authors
  1. B. Schieffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Drexler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schieffer, B., Drexler, H. Therapie der chronischen Herzinsuffizienz mit ACE-Hemmern versus AT1-Rezeptor-Antagonisten. Herz 22, 357–360 (1997). https://doi.org/10.1007/BF03044289

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03044289

Search

Navigation